Lymphoma Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2021-11-27
Nov 27, 2021
M
Completed
  • Lymphoma
  • 3RP-Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-11-09
Nov 9, 2021
A
Recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Boston, Massachusetts
  • +3 more
2021-11-05
Nov 5, 2021
T
Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +26 more
2021-11-03
Nov 3, 2021
M
Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +17 more
2021-11-02
Nov 2, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
2021-10-26
Oct 26, 2021
M
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
2021-10-25
Oct 25, 2021
M
Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021
D
Not yet recruiting
  • Lymphoma
  • Survivorship
  • Interview with Clinicians
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-10-05
Oct 5, 2021
D
Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-10-12
Oct 12, 2021
L
Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
2021-10-11
Oct 11, 2021
M
Recruiting
  • Lymphoma
  • Miami, Florida
  • +6 more
2021-09-29
Sep 29, 2021
F
Not yet recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
2021-09-20
Sep 20, 2021
R
Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
2021-09-20
Sep 20, 2021
M
Withdrawn
  • Lymphoma
  • Home Hospital for Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-08-31
Aug 31, 2021
C
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
C
Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2021-08-23
Aug 23, 2021
I
Recruiting
  • Advanced Solid Tumors
  • Lymphoma
  • New Haven, Connecticut
  • +5 more
2021-08-17
Aug 17, 2021
A
Active, not recruiting
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
2021-08-16
Aug 16, 2021